苯丙氨酸
泌尿系统
氨基酸
化学
内分泌学
内科学
排泄
等离子体
药理学
医学
生物化学
物理
量子力学
作者
Heike J. Wobst,Andreu Viader,Giovanni Muncipinto,Ryan Hollibaugh,Daniel van Kalken,Christopher T Burkhart,Susan Cantin,Rachel M. Bates,Yannik Régimbald‐Dumas,Liam Gross,Matthew Antalek,J. E. Zweig,Frank Wu,T.J. Rettenmaier,Matthew Labenski,Nick Pullen,Heather Blanchette,Jaclyn L. Henderson,Haoling H. Weng,Toby A Vaughn
出处
期刊:JCI insight
[American Society for Clinical Investigation]
日期:2024-11-07
卷期号:9 (21)
被引量:2
标识
DOI:10.1172/jci.insight.182876
摘要
BACKGROUNDThe toxic accumulation of phenylalanine (Phe) in the brain underlies the neurological presentation of phenylketonuria (PKU). Solute carrier family 6 member 19 (SLC6A19) is the major transporter responsible for the (re)absorption of Phe in the kidney and intestine. Here, we describe the characterization of the first small molecule SLC6A19 inhibitor to enter clinical development for the treatment of PKU.METHODSC57Bl/6J WT and Pahenu2 mice were dosed with an inhibitor of SLC6A19 to investigate the effects on urinary amino acids and plasma Phe. In a phase 1 study, healthy human volunteers were dosed with JNT-517, an investigational oral inhibitor of SLC6A19. The primary objective of the study was safety. Secondary objectives included pharmacokinetic and pharmacodynamic studies.RESULTSInhibition of SLC6A19 increased the urinary excretion of Phe in a mouse model of PKU, thereby reducing plasma Phe levels. JNT-517, an investigational oral SLC6A19 inhibitor, was found to be safe and well tolerated and increased the urinary excretion of Phe in a phase 1 healthy volunteer study.CONCLUSIONSThese data indicate that pharmacological inhibition of SLC6A19 presents a promising approach to lower toxic elevated levels of amino acids found in PKU and related amino acid metabolism disorders by facilitating their renal elimination.TRIAL REGISTRATIONAustralian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12622001222730.FUNDINGThe studies in this paper were funded by Jnana Therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI